Safety Shot Receives 180-Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Requirement
Safety Shot (Nasdaq: SHOT) has received a 180-day extension from Nasdaq until December 29, 2025, to regain compliance with the minimum bid price requirement. The extension was granted based on the company meeting all other Nasdaq Capital Market listing requirements except the bid price requirement.
The company's stock will continue trading on Nasdaq under "SHOT" while it works to meet the minimum $1.00 bid price requirement for at least 10 consecutive business days. CEO Jarrett Boon noted that the Board has approved several strategic options to address this requirement while focusing on business strategy and Yerbaé integration.
Safety Shot (Nasdaq: SHOT) ha ottenuto una proroga di 180 giorni da Nasdaq fino al 29 dicembre 2025 per tornare conforme al requisito del prezzo minimo di offerta. La proroga è stata concessa poiché la società soddisfa tutti gli altri requisiti di quotazione del Nasdaq Capital Market, ad eccezione del requisito del prezzo di offerta.
Le azioni della società continueranno a essere negoziate su Nasdaq con il simbolo "SHOT" mentre si lavora per raggiungere il requisito del prezzo minimo di offerta di 1,00 dollaro per almeno 10 giorni lavorativi consecutivi. Il CEO Jarrett Boon ha sottolineato che il Consiglio di Amministrazione ha approvato diverse opzioni strategiche per affrontare questo requisito, mantenendo l’attenzione sulla strategia aziendale e sull’integrazione di Yerbaé.
Safety Shot (Nasdaq: SHOT) ha recibido una extensión de 180 días por parte de Nasdaq hasta el 29 de diciembre de 2025 para recuperar el cumplimiento con el requisito mínimo del precio de oferta. La extensión fue concedida porque la empresa cumple con todos los demás requisitos de listado del Nasdaq Capital Market, excepto el requisito del precio de oferta.
Las acciones de la compañía continuarán cotizando en Nasdaq bajo el símbolo "SHOT" mientras trabajan para cumplir con el requisito mínimo de precio de oferta de $1.00 durante al menos 10 días hábiles consecutivos. El CEO Jarrett Boon señaló que la Junta Directiva ha aprobado varias opciones estratégicas para abordar este requisito, enfocándose en la estrategia comercial y la integración de Yerbaé.
Safety Shot (나스닥: SHOT)은 최소 입찰가 요건을 충족하기 위해 나스닥으로부터 180일 연장을 받아 2025년 12월 29일까지 기한이 연장되었습니다. 이 연장은 회사가 입찰가 요건을 제외한 모든 나스닥 캐피털 마켓 상장 요건을 충족했기 때문에 승인되었습니다.
회사의 주식은 최소 $1.00 입찰가 요건을 연속 10 영업일 이상 충족하기 위해 노력하는 동안 "SHOT"이라는 티커로 나스닥에서 계속 거래됩니다. CEO Jarrett Boon은 이사회가 사업 전략과 Yerbaé 통합에 집중하면서 이 요건을 해결하기 위한 여러 전략적 옵션을 승인했다고 밝혔습니다.
Safety Shot (Nasdaq : SHOT) a obtenu une prolongation de 180 jours de la part de Nasdaq jusqu'au 29 décembre 2025 pour retrouver la conformité avec l'exigence de prix d'offre minimum. Cette prolongation a été accordée car la société respecte toutes les autres exigences de cotation du Nasdaq Capital Market, à l'exception de l'exigence sur le prix d'offre.
Les actions de la société continueront à être négociées sur Nasdaq sous le symbole "SHOT" pendant qu'elle s'efforce de satisfaire à l'exigence minimale de prix d'offre de 1,00 $ pendant au moins 10 jours ouvrables consécutifs. Le PDG Jarrett Boon a indiqué que le conseil d'administration a approuvé plusieurs options stratégiques pour répondre à cette exigence, tout en se concentrant sur la stratégie commerciale et l'intégration de Yerbaé.
Safety Shot (Nasdaq: SHOT) hat eine 180-tägige Verlängerung von Nasdaq bis zum 29. Dezember 2025 erhalten, um die Einhaltung der Mindestgebotspreisanforderung wiederherzustellen. Die Verlängerung wurde gewährt, da das Unternehmen alle anderen Nasdaq Capital Market-Listenanforderungen außer der Gebotspreisanforderung erfüllt.
Die Aktien des Unternehmens werden weiterhin unter dem Symbol "SHOT" an der Nasdaq gehandelt, während daran gearbeitet wird, die Mindestgebotspreisanforderung von 1,00 USD für mindestens 10 aufeinanderfolgende Handelstage zu erfüllen. CEO Jarrett Boon bemerkte, dass der Vorstand mehrere strategische Optionen genehmigt hat, um diese Anforderung anzugehen, während der Fokus auf der Geschäftsstrategie und der Integration von Yerbaé liegt.
- Board has proactively approved strategic options to address compliance
- Company meets all other Nasdaq listing requirements
- Additional 180 days provided to regain compliance
- Opportunity to appeal if compliance not met by deadline
- Risk of delisting if $1.00 minimum bid price not maintained for 10 consecutive days by December 29, 2025
- Current stock price remains below Nasdaq minimum requirement
- Potential need for strategic actions that could impact shareholders
Insights
Safety Shot received crucial 180-day Nasdaq extension to meet $1 minimum share price requirement, avoiding immediate delisting risk.
Safety Shot has been granted a significant 180-day extension from Nasdaq to regain compliance with the minimum bid price requirement, extending their deadline to December 29, 2025. This extension indicates that while the company's stock price has been trading below the required $1.00 minimum threshold, they've met all other Nasdaq Capital Market listing requirements, including adequate market value of publicly held shares.
This development has no immediate impact on Safety Shot's listing status, as their shares will continue trading under the "SHOT" symbol. However, the extension represents a critical regulatory reprieve that buys management valuable time to implement remedial measures. To satisfy the requirement, Safety Shot needs to maintain a closing bid price of at least $1.00 for a minimum of 10 consecutive business days during this extension period.
The CEO's statement that the board has "proactively approved several strategic options" likely indicates they're considering potential remedies such as a reverse stock split, which would artificially increase the share price by reducing the number of outstanding shares. The company's reference to the "exciting integration of Yerbaé" suggests they're also banking on business developments to potentially drive organic share price appreciation.
If Safety Shot fails to regain compliance by the December deadline, they face potential delisting, though they would still have appeal rights before a Nasdaq Hearings Panel. This extension essentially represents a yellow warning flag rather than an immediate red flag for investors.
SCOTTSDALE, AZ, July 16, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”) today announced it has received a notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq") granting the Company an additional 180-calendar day compliance period, until December 29, 2025, to regain compliance with the minimum bid price requirement.
Nasdaq's determination is based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and the Company’s written notice of its intention to cure the deficiency during the second compliance period.
This notification has no immediate effect on the listing of the Company’s common stock, which will continue to trade on The Nasdaq Capital Market under the ticker symbol “SHOT”.
“We are pleased to have received this extension from Nasdaq, which provides us with additional time to regain compliance,” said Jarrett Boon, CEO of Safety Shot. “Our Board of Directors has already proactively approved several strategic options to satisfy the bid price requirement. We will continue to monitor our stock price and are confident in our ability to resolve this matter within the extended compliance period, ensuring our focus remains on executing our business strategy and completing the exciting integration of Yerbaé.”
To regain compliance, the closing bid price of the Company’s common stock must be at least
About Safety Shot, Inc. Safety Shot, Inc., a wellness and dietary supplement company, has developed Sure Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy, and overall mood. Sure Shot is available for purchase online at www.sureshot.com, www.walmart.com and Amazon.
Investor Relations: Phone: 561-244-7100 Email: investors@drinksafetyshot.com
Forward-Looking Statements: This press release contains forward-looking statements, including statements about the Company’s ability to regain compliance with the Nasdaq minimum bid price requirement. These forward-looking statements are based on the current expectations of the management of Safety Shot and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Safety Shot, Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
FAQ
What is the deadline for Safety Shot (SHOT) to regain Nasdaq compliance?
Will Safety Shot (SHOT) be delisted from Nasdaq immediately?
What happens if Safety Shot (SHOT) fails to meet Nasdaq requirements by the deadline?
What requirements did Safety Shot (SHOT) meet to receive the Nasdaq extension?
What actions is Safety Shot (SHOT) taking to maintain Nasdaq listing?
